South African Medical News

Back to Home Page

Print using browser
Aspen - launch - Pexasp 0,125 mg, 0,25 mg and 1 mg tablets (pramipexole)

aspen logo

Dear Healthcare Professional

Aspen has pleasure in launching  PEXASP 0,125 mg, PEXASP 0,25 mg and PEXASP 1 mg tablets. Each PEXASP tablet contains 0,125 mg, 0,25 mg, or 1 mg pramipexole as pramipexole dihydrochloride monohydrate respectively.

PEXASP is available from your nearest wholesaler.

If you have any further queries, please contact your Aspen representative, or the Aspen Medical Affairs Hotline on 0800 118 088.

        * This is a drug - read the leaflet carefully before use. 

        * Ask your doctor or pharmacist for further information. 

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

Aspen thank you for your continued support and assure you of their commitment to service excellence at all times.


pexasp0.125mgpack.jpg

pexasp0.25mgpack pexasp1mgpack



















Marketed by Aspen Pharmacare, Building 12, Healthcare Park,Woodlands Drive, Woodmead, 2191.

S4 PEXASP 0,125 mg (tablets). Reg. No.: 42/5.4.1/1023. Each tablet contains 0,125 mg pramipexole as pramipexole dihydrochloride monohydrate. S4 PEXASP 0,25 mg (tablets). Reg. No.: 42/5.4.1/1022. Each tablet contains 0,25 mg pramipexole as pramipexole dihydrochloride monohydrate. S4 PEXASP 1 mg (tablets). Reg. No.: 42/5.4.1/1024. Each tablet contains 1 mg pramipexole as pramipexole dihydrochloride monohydrate.

You need to be logged in to see more details. Register Now!


Click here to visit the Aspen website....
Contact: Kuven Govender, Brand Manager: Priority Commodity-CNS focus, Backshop
Telephone: +27 (0) 11 239 6061
E-mail: KGovender3@aspenpharma.com
Date: Monday, May 7, 2018